PR
PreveCeutical Medical Inc.
PRVCF · OTC
$0.01 +0.00% (+$0.00)
1M -40.12%
Market Cap $13.6M
P/E Ratio -
Div. Yield -
ROE -
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
2/9Valuation
-
N/A P/E N/A
EV/EBITDA N/A
P/S N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
57 /100
Average ROIC 339.03%
ROA 109.38%
Asset turnover 0.00x
Debt
0 /100
High Current ratio 0.15x
Int. coverage -10.44x
Debt/Equity N/A
Stability
39 /100
Moderate Beta 0.07x
EPS volatility 19.88%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about PRVCF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Stephen Van Deventer
Employees
7
Headquarters
Vancouver